Cargando…
The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber
OBJECTIVE: The study objective was to investigate the prophylactic efficacy of montelukast (MLK) 10 mg in suppressing seasonal allergic rhinitis (SAR) symptoms induced by Japanese cedar (JC) pollen and to determine how many days before exposure to JC in the artificial exposure chamber (OHIO chamber)...
Autores principales: | Hashiguchi, Kazuhiro, Okubo, Kimihiro, Wakabayashi, Ken-ichiro, Tanaka, Nobuaki, Watada, Yukiko, Suematsu, Kiyochika, Gotoh, Minoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980728/ https://www.ncbi.nlm.nih.gov/pubmed/27536427 http://dx.doi.org/10.3109/21556660.2012.728547 |
Ejemplares similares
-
Efficacy of fluticasone furoate nasal spray and levocetirizine in patients with Japanese cedar pollinosis subjected to an artificial exposure chamber
por: Hashiguchi, Kazuhiro, et al.
Publicado: (2013) -
Evaluation of Montelukast for the Treatment of Children With Japanese
Cedar Pollinosis Using an Artificial Exposure Chamber (OHIO
Chamber)
por: Hashiguchi, Kazuhiro, et al.
Publicado: (2018) -
Histamine antagonist Bepotastine suppresses nasal symptoms caused by Japanese cedar and cypress pollen exposure
por: Kanzaki, Sho, et al.
Publicado: (2016) -
Placebo-controlled study with OHIO chamber of prophylactic pranlukast for children with Japanese cedar pollinosis: TOPIC-J III study
por: Hosoya, Kei, et al.
Publicado: (2014) -
Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis
por: Kurokawa, Tomoya, et al.
Publicado: (2022)